{
    "title": "Merck scraps third prostate cancer study as Keytruda therapy disappoints",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11802483/Merck-discontinue-Keytruda-combination-study-prostate-cancer.html",
    "date": "2023-02-28",
    "keywords": [
        "cancer",
        "combination",
        "therapy",
        "treatment",
        "prostate",
        "bhanvi",
        "satija",
        "trial",
        "drug",
        "disease",
        "type",
        "latestage",
        "study",
        "class",
        "goldstein",
        "merck",
        "inc",
        "co",
        "tuesday",
        "data",
        "behind",
        "checkpoint",
        "death",
        "protein",
        "immune",
        "system",
        "decision",
        "surprise",
        "mara",
        "analyst",
        "cost",
        "relative",
        "return",
        "analysis",
        "survival",
        "time",
        "patient",
        "rate",
        "group",
        "drugmaker",
        "blockbuster",
        "immunotherapy",
        "deprivation",
        "xtandi",
        "pfizer",
        "form",
        "keytruda",
        "goal",
        "lung",
        "body",
        "company",
        "trading",
        "reporting",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}